Bayer to Pay $15 Million to Settle Aspirin Marketing Suit

A Bayer AG unit will pay $15 million to settle a U.S. lawsuit claiming it illegally marketed aspirin mixed with supplements.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.